DCM Shriram Fine Chemicals Limited
DSFCL (NSE) · DSFCL (BSE 544703) · ISIN INE0OFM01015 · Specialty Chemicals · listed 2026 · website
Not on any surveillance list
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹90.78 cr and profit after tax ₹2.42 cr.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹90.78 cr | ₹2.42 cr | 0.28 | 14 Aug 2026 |
| Q4 FY26 standalone | ₹93.08 cr | −₹4.08 cr | −0.47 | 19 May 2026 |
| Q3 FY26 standalone | ₹96.95 cr | −₹1.62 cr | −0.19 | 4 May 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹200.37 cr | ₹7.83 cr | ₹284.71 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 50.11% | 0.97% | 11.20% | 49.89% |
Latest filings
- Alok Bansidhar Shriram has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in 19 October 2026 · NSE
- Annual Report FY2025-26 (New) 6 October 2026 · NSE
- DCM Shriram Fine Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026. 3 September 2026 · NSE
- DCM Shriram Fine Chemicals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. 14 August 2026 · NSE
- DCM Shriram Fine Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 14, 2026. 14 July 2026 · NSE
Other companies in Specialty Chemicals
- BASF India Limited
- Pidilite Industries Limited
- SRF Limited
- Aarti Industries Limited
- Atul Limited
- Gujarat Fluorochemicals Limited
- Jubilant Ingrevia Limited
- Galaxy Surfactants Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.